Otsuka's Head of U.S. GPV Safety Data Management Vikalp Khare shares how smart governance should inform pharmacovigilance (PV) technology choices.
- Safe And Sustainable DCTs and Hybrid Trials (Part 2)
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How Cara Therapeutics Increased Compliance And Reduced Study Team Burden
Delve into the partnership that helped Cara Therapeutics achieve a significant milestone in their clinical research efforts to transform the lives of chronic pruritus patients.
-
Strategies For More Accurate Clinical Trial Forecasting And Budgeting
Explore some of the best strategies and practices to ensure clinical trial staff get approval for their budgets, with forecasts as accurate as possible.
-
ePROM Implementation: 4 Best Practices For System Functionality
Explore four of the 15 system functionality considerations highlighted in an eCOA Consortium article that aim to create a more thorough and standardized approach to ePROM implementation.
-
Nevro Eliminates Majority Of Source Data Verification With ePRO And EDC
Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.
-
Enhancing Information Dissemination
By utilizing advanced digital solutions, Medical Affairs (MA) teams can optimize workflows, reduce their operational burdens, and elevate the quality of communication.
-
Opportunities For Enhancing Signal Detection In Schizophrenia Trials
Signal detection in schizophrenia trials is hindered by increased placebo response, complex rating scales, inconsistent rater performance, and data quality issues.
-
10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them
Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.
-
Redefining Evidence Generation In Modern Clinical Trials
As trials continue to digitize, learn how connected sensors, COAs, PROs, and other forms of data will come together to form the evidence of tomorrow.
-
How eSource Reduced Benchmark's Protocol Deviations By Almost 40%
Explore how a leading vaccine site network selected CRIO to help address the challenges with it's use of paper charts in collecting source data.
-
How RFI/RFP Optimization Changes The Game
Selecting the right vendors can determine whether a clinical trial advances smoothly or stalls under budget overruns and delays.
FROM THE EDITOR
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders